Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 780 participants.

Also called NCT06310031

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 780 participants (planned count) (from the registry)
Sponsor
BrioHealth Solutions, Inc. (from the registry)
Registry
  • NCT NCT06310031
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06310031. Randomized; no masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2028-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Acronym
INNOVATE
Condition
Cardiovascular Diseases
Condition
Heart Diseases
Condition
Heart Failure
Intervention (Device)
BrioVAD System
Intervention (Device)
HeartMate 3
Lead sponsor
BrioHealth Solutions, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06310031
Content hash
86ef0b37cbf85d2a9b93e35e54cf11b1953ca0753a53f097f599f6be054eb997